|
|
|
|
|
1998 Archived News
|
|
- Hormone Linked with Obesity
:
[December 15, 1998] Scientists at Joslin Diabetes Center and Beth Israel Deaconess Medical Center in Boston have identified a hormone in mice which, when absent, causes animals to eat less, burn more energy and weigh less compared to animals with the hormone.
- FDA Approves Laser Product to Use in Place of Lancets for Diabetes Testing
:
[December 8, 1998] The Federal Food and Drug Administration this week approved for home use a battery-operated laser device that can be used in place of lancets to obtain a blood sample for doing home blood sugar monitoring.
- Joslin Diabetes Center Names Senior Vice President for Strategic Business Initiatives
:
[December 4, 1998] Alan M. Jacobson, M.D., has been appointed Senior Vice President for Strategic Business Initiatives at Joslin Diabetes Center, where he will head a new division responsible for a variety of initiatives at the Center, including its Affiliated Centers franchise program, its international programs and continuing medical education initiatives.
- Work on Oral and Inhaled Insulin Progresses
:
[November, 1998] Announcements from companies in the US and Canada indicate that progress is being made to develop oral or inhaled insulins as alternatives to injected insulins for people with diabetes. Clinical trials still must be completed and analyzed before the FDA can review these products, however.
- Improved Glucose Control Improves Work Productivity and Emotional Well Being, Study Shows
:
[November, 1998] A study published in the November 3 issue of the Journal of the American Medical Association shows that patients with type 2 diabetes who decreased their blood sugar levels through a combination of diet and medication enjoyed immediate benefits in terms of an improved quality of life and increased employment productivity.
- Early Results of Clinical Trial Data in Diabetic Eye Study Are Promising, Joslin Researchers Report
:
[October, 1998] A compound being evaluated as a possible oral treatment for diabetic retinopathy, a leading cause of blindness in adults with diabetes, was found to be safe under study conditions and to normalize some characteristics in the eyes of people with diabetes that are associated with eye complications, according to researchers at Joslin Diabetes Center.
- Being Overweight May Be More in the Genes Than Previously Thought
:
[October, 1998] Scientists at Joslin Diabetes Center in Boston have found one more clue that obesity may be a genetically-determined disorder. Their study, published in a recent issue of the New England Journal of Medicine, has identified a new human gene mutation associated with obesity.
- UK Study Shows Tight Control Benefits Type 2 Patients
:
[September, 1998] A new study called the United Kingdom Prospective Diabetes Study has demonstrated conclusively that closely managing patients with type 2 diabetes to keep their blood sugars as near to normal as possible will decrease their risk of complications such as eye and kidney disease by as much as 25 percent.
- Makers of Rezulin Issue Additional Use Guidelines
:
[July, 1998] The U.S. Food and Drug Administration has announced that patients taking the type 2 diabetes drug Rezulin (troglitazone) should be monitored even more frequently for signs of injury to the liver. This announcement came amid calls from a consumer group to remove the drug from the market.
- LifeScan Recalls Some SureStep Meters
:
[July, 1998] The Food and Drug Administration and LifeScan is asking all patients who use SureStep Consumer Meters made before August, 1997 to call for important information about how to get a free replacement meter. The meters being recalled may give an "ER1" (Error 1) message if a patient's blood sugar is very high and a patient's failure to recognize a seriously high blood sugar level could cause serious health consequences.
- Medicare Begins Covering Glucose Test Supplies
:
[July, 1998] Beginning July 1, Medicare began covering blood glucose test strips, lancets and meters whether you use insulin to control your diabetes or not.
|
|
|
|
